64Cu-DOTA-Trastuzumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 64Cu-DOTA-Trastuzumab, covering 2026-02-23 to 2026-02-23. Get the full timeline:
Most recent: Clinical Trial Update: An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis [Phase 4]